To test the contribution of IGF1R in ALK-driven NB cells, we treated CLB-BAR, CLB-GAR, CLB-GE, and NB1 cells with GSK1904529A, a selective and potent IGF1R inhibitor [52]. The gene discussed is CLYBL; the disease is neuroblastoma.